Inconsistent quality of evidence for biomarker use on FDA drug labels
1. The majority of drug labels for drug-biomarker combinations did not provide convincing evidence for clinical validity or utility. 2. ...
Tag: FDA
![Novel biodegradable sirolimus-eluting stents non-inferior to durable everolimus-eluting stents [BIOSCIENCE trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/Taxus_stent_FDA-e1607803635904-350x250.jpg)
Effectiveness of medical device postapproval surveillance unclear
1. The effectiveness of the present FDA-mandated postapproval study program is unclear, due in large part to variability in characteristics ...
Atypical antipsychotics linked with acute kidney injury in the elderly
1. Atypical antipsychotics given to elderly patients in outpatient setting were associated with a 75% increased 90-day risk of hospitalization ...
2 Minute Medicine Rewind January 27-February 2, 2014
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
2 Minute Medicine Rewind Jan 20 – Jan 26, 2014
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
